vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
Piedmont Realty Trust, Inc. is the larger business by last-quarter revenue ($143.3M vs $85.1M, roughly 1.7× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -31.4%, a 54.2% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 0.4%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 0.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
FDMT vs PDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $143.3M |
| Net Profit | $19.4M | $-45.0M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | — |
| Net Margin | 22.8% | -31.4% |
| Revenue YoY | 8508900.0% | 0.4% |
| Net Profit YoY | 139.1% | -27.9% |
| EPS (diluted) | $0.43 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $143.3M | ||
| Q4 25 | $85.1M | $142.9M | ||
| Q3 25 | $90.0K | $139.2M | ||
| Q2 25 | $15.0K | $140.3M | ||
| Q1 25 | $14.0K | $142.7M | ||
| Q4 24 | $1.0K | $143.2M | ||
| Q3 24 | $3.0K | $139.3M | ||
| Q2 24 | $5.0K | $143.3M |
| Q1 26 | — | $-45.0M | ||
| Q4 25 | $19.4M | $-43.2M | ||
| Q3 25 | $-56.9M | $-13.5M | ||
| Q2 25 | $-54.7M | $-16.8M | ||
| Q1 25 | $-48.0M | $-10.1M | ||
| Q4 24 | — | $-30.0M | ||
| Q3 24 | $-43.8M | $-11.5M | ||
| Q2 24 | $-35.0M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | 17.3% | — | ||
| Q3 25 | -67983.3% | — | ||
| Q2 25 | -396373.3% | — | ||
| Q1 25 | -383007.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1704400.0% | — | ||
| Q2 24 | -849120.0% | — |
| Q1 26 | — | -31.4% | ||
| Q4 25 | 22.8% | -30.3% | ||
| Q3 25 | -63195.6% | -9.7% | ||
| Q2 25 | -364386.7% | -12.0% | ||
| Q1 25 | -342657.1% | -7.1% | ||
| Q4 24 | — | -20.9% | ||
| Q3 24 | -1461433.3% | -8.3% | ||
| Q2 24 | -699060.0% | -6.8% |
| Q1 26 | — | $-0.10 | ||
| Q4 25 | $0.43 | $-0.34 | ||
| Q3 25 | $-1.01 | $-0.11 | ||
| Q2 25 | $-0.98 | $-0.14 | ||
| Q1 25 | $-0.86 | $-0.08 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | $-0.79 | $-0.09 | ||
| Q2 24 | $-0.63 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $2.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $1.5B |
| Total Assets | $566.7M | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.3M | ||
| Q4 25 | $402.7M | $731.0K | ||
| Q3 25 | $305.1M | $3.0M | ||
| Q2 25 | $293.2M | $3.3M | ||
| Q1 25 | $321.4M | $2.9M | ||
| Q4 24 | $424.9M | $109.6M | ||
| Q3 24 | $501.9M | $133.6M | ||
| Q2 24 | $541.9M | $138.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $505.7M | $1.5B | ||
| Q3 25 | $369.0M | $1.5B | ||
| Q2 25 | $420.9M | $1.5B | ||
| Q1 25 | $469.7M | $1.6B | ||
| Q4 24 | $510.6M | $1.6B | ||
| Q3 24 | $552.9M | $1.6B | ||
| Q2 24 | $588.3M | $1.7B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $566.7M | $4.0B | ||
| Q3 25 | $424.0M | $4.0B | ||
| Q2 25 | $473.6M | $4.0B | ||
| Q1 25 | $515.7M | $4.0B | ||
| Q4 24 | $560.4M | $4.1B | ||
| Q3 24 | $604.0M | $4.1B | ||
| Q2 24 | $620.1M | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 1.41× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | — |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | 110.3% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.6M | $140.6M | ||
| Q3 25 | $-46.5M | $35.8M | ||
| Q2 25 | $-43.4M | $50.1M | ||
| Q1 25 | $-47.8M | $3.7M | ||
| Q4 24 | $-134.6M | $198.1M | ||
| Q3 24 | $-29.4M | $42.9M | ||
| Q2 24 | $-30.2M | $66.8M |
| Q1 26 | — | — | ||
| Q4 25 | $28.5M | — | ||
| Q3 25 | $-46.6M | — | ||
| Q2 25 | $-43.4M | — | ||
| Q1 25 | $-48.4M | — | ||
| Q4 24 | $-138.4M | — | ||
| Q3 24 | $-31.2M | — | ||
| Q2 24 | $-30.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 33.5% | — | ||
| Q3 25 | -51765.6% | — | ||
| Q2 25 | -289620.0% | — | ||
| Q1 25 | -345635.7% | — | ||
| Q4 24 | -13837100.0% | — | ||
| Q3 24 | -1038966.7% | — | ||
| Q2 24 | -611840.0% | — |
| Q1 26 | — | 110.3% | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 101.1% | — | ||
| Q2 25 | 440.0% | — | ||
| Q1 25 | 4507.1% | — | ||
| Q4 24 | 378600.0% | — | ||
| Q3 24 | 59266.7% | — | ||
| Q2 24 | 6980.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
